Orbimed Advisors, 10% Owner: NeuroPace NPCE Sell · Filed 24/04/18

Trade details

Type: Insider sale
Amount: $197,106.69
Shares · price: 14,069 sh · $14.01 a share
Held after: 3,504,898 sh
Stock: NeuroPace NPCE
Person: Orbimed Advisors10% Owner
Trade date: 24/04/16
Filed: 24/04/18
Days to filing: 2 days

Sold 0.4% of holdings

Share of holding sold: 0.4%

NeuroPace trades, last 26 weeks

What else happened in NeuroPace around then

Filed or reported within 30 days of the trade day · 24/03/17~24/05/16

Orbimed Advisors's recent trades

Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$10M
588,235 sh
$10M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$5.1M
300,249 sh
$5.1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyADARx Pharmaceuticals
Buy
ADARx Pharmaceuticals
ADRX
$1M
61,516 sh
$1M
Filed 09/30
Traded 09/28
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$15M
1,000,000 sh
$15M
Filed 09/23
Traded 09/21
Orbimed AdvisorsDirector
BuyElectra Therapeutics
Buy
Electra Therapeutics
ETRA
$5M
333,333 sh
$5M
Filed 09/23
Traded 09/21